Medical Developments International Stock Shares Outstanding
| MVP Stock | 0.42 0.01 2.44% |
Medical Developments International fundamentals help investors to digest information that contributes to Medical Developments' financial success or failures. It also enables traders to predict the movement of Medical Stock. The fundamental analysis module provides a way to measure Medical Developments' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medical Developments stock.
Medical |
Medical Developments International Company Shares Outstanding Analysis
Medical Developments' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Medical Developments Shares Outstanding | 112.66 M |
Most of Medical Developments' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Developments International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Medical Developments International has 112.66 M of shares currently outstending. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all Australia stocks is notably lower than that of the firm.
Medical Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Developments' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medical Developments could also be used in its relative valuation, which is a method of valuing Medical Developments by comparing valuation metrics of similar companies.Medical Developments is currently under evaluation in shares outstanding category among its peers.
Medical Fundamentals
| Return On Equity | -0.65 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (1.24) % | |||
| Operating Margin | (0.15) % | |||
| Current Valuation | 39.87 M | |||
| Shares Outstanding | 112.66 M | |||
| Shares Owned By Insiders | 16.77 % | |||
| Shares Owned By Institutions | 25.14 % | |||
| Price To Book | 1.03 X | |||
| Price To Sales | 1.41 X | |||
| Revenue | 33.15 M | |||
| Gross Profit | 22.21 M | |||
| EBITDA | (29.45 M) | |||
| Net Income | (40.99 M) | |||
| Cash And Equivalents | 24.66 M | |||
| Total Debt | 2.29 M | |||
| Book Value Per Share | 0.53 X | |||
| Cash Flow From Operations | (10.78 M) | |||
| Earnings Per Share | (0.46) X | |||
| Target Price | 2.94 | |||
| Beta | 1.53 | |||
| Market Capitalization | 46.75 M | |||
| Total Asset | 59.16 M | |||
| Retained Earnings | (62.86 M) | |||
| Working Capital | 16.59 M | |||
| Net Asset | 59.16 M |
About Medical Developments Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Developments International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Developments using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Developments International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medical Stock Analysis
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.